Citations

Citations to this article as recorded by  

• Alterations of Nutrient Elements in Hepatocellular Carcinoma Patients Treated with Atezolizumab-Bevacizumab
  Shuyue Xiao, Xiaohui Huang, Shuer Liu, Di Jin, Zheng Liu
  Nutrition and Cancer.2025; 77(2): 244.     CrossRef
• Structure–activity relationship studies of Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma
  Jisook Kim, Seung Hyun Jung, Joo Chan Lee, Won Jeoung Kim, Jooyun Byun, Young Gil Ahn, Hyun-Ju Park
  European Journal of Medicinal Chemistry.2025; 282: 117047.     CrossRef
• Liver cancer in Saudi Arabia: A registry-based nationwide descriptive epidemiological and survival analysis
  Nawal H. Almohammadi
  Cancer Epidemiology.2025; 94: 102731.     CrossRef
• Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpression
  Steffen Markus Heckl, Carolin Schneider, Lukas Kercher, Hans-Michael Behrens, Jan-Paul Gundlach, Alexander Bernsmeier, Stephan Schmidt, Sandra Krüger, Felix Braun, Rainer Günther, Thomas Becker, Stefan Schreiber, Christoph Röcken
  Scientific Reports.2025;[Epub]     CrossRef
• Therapeutic Effects of Crocin Nanoparticles Alone or in Combination with Doxorubicin against Hepatocellular Carcinoma In vitro
  Noha S. Basuony, Tarek M. Mohamed, Doha M. Beltagy, Ahmed A. Massoud, Mona M. Elwan
  Anti-Cancer Agents in Medicinal Chemistry.2025; 25(3): 194.     CrossRef
• Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
  Masaud Shah, Muhammad Hussain, Hyun Goo Woo
  Genomics & Informatics.2025;[Epub]     CrossRef
• Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
  Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
  Clinical and Molecular Hepatology.2025; 31(1): 166.     CrossRef
• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
  Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
  Cancers.2025; 17(4): 566.     CrossRef
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Targeting metabolic diseases with celastrol: A comprehensive review of anti-inflammatory mechanisms and therapeutic potential
  Xiaojuan Wang, Mohamad Hafizi Abu Bakar, Song Liqun, Mohd Asyraf Kassim, Khairul Anuar Shariff, Thiruventhan Karunakaran
  Journal of Ethnopharmacology.2025; 344: 119560.     CrossRef
• Advancements in autoimmune hepatitis epidemiology, treatment and complication – a 15-year retrospective study
  Mifleh Tatour, Fadi Abu Baker, Tarek Saadi, Ahmad Yahia, Rawi Hazzan
  Clinics and Research in Hepatology and Gastroenterology.2025; 49(4): 102570.     CrossRef
• Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia‐Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021
  Suprabhat Giri, Sushrut Ingawale, Gaurav Khatana, Prasanna Gore, Dibya Lochan Praharaj, Vincent Wai‐Sun Wong, Daniel Q. Huang, Amit Singhal, Ashok Choudhury
  Journal of Gastroenterology and Hepatology.2025; 40(5): 1188.     CrossRef
• Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
  Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, Dominik Malicki, Aleksandra Piąta, Dominika Lorek, Jakub Janczura
  Medical Oncology.2025;[Epub]     CrossRef
• Investigating the functional role of BUB1B in aflatoxin B1-associated hepatocarcinogenesis
  Hayam Hamdy, Wafaa A. Aly, Eyad Elkord
  Toxicology.2025; 514: 154127.     CrossRef
• Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma
  Jin Sun Kim, Won-Mook Choi, Ha-Il Kim, Sung Won Chung, Jonggi Choi, Danbi Lee, Kang Mo Kim
  Journal of Liver Cancer.2025; 25(1): 79.     CrossRef
• Association between allopurinol and hepatocellular carcinoma: analysis of genetic risk and patient survival
  Yu-fu Li, Hui-wei Wang, Huan-yan Peng, Zhen-ying Zhang, Zhi-jia Yao, Yuan Meng, Dong-ye Yang
  Discover Oncology.2025;[Epub]     CrossRef
• A Comparative Analysis of the Roles of von Willebrand Factor and ADAMTS13 in Hepatocellular Carcinoma: A Bioinformatics and Microarray-Based Study
  Durmuş Ayan, Şerife Buket Bozkurt Polat, Ergül Bayram, Esma Özmen, Fatma Esin Aydın, Serpil Ersan
  Current Issues in Molecular Biology.2025; 47(4): 270.     CrossRef
• Hepatitis B virus genotype distribution and mutation patterns: Insights and clinical implications for hepatitis B virus positive patients
  Manisha M Ratnaparkhi, Chanda R Vyawahare, Nageswari R Gandham
  World Journal of Experimental Medicine.2025;[Epub]     CrossRef
• Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
  Hyuk Soo Eun
  Clinical and Molecular Hepatology.2025; 31(2): e215.     CrossRef
• Construction of a tumor immune microenvironment-related risk scoring model for prognosis of hepatocellular carcinoma
  Xinyi Li, Zifan Qin, Haozhi Chen, Daichuan Chen, Nafisa Alimu, Duoduo Li, Xiyu Cheng, Qiong Yan, Lishu Zhang, Xingwei Liu, Zitong Zhou, Jiayi Zhu, Hangqi Ma, Xinyue Pei, Hanli Xu, Jiaqiang Huang
  International Journal of Immunopathology and Pharmacology.2025;[Epub]     CrossRef
• Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP‐1RA in CHB and T2DM Patients
  Byungyoon Yun, Juyeon Oh, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin‐Ha Yoon
  Liver International.2025;[Epub]     CrossRef
• Bioinformatics-driven identification of key non-invasive prognostic biomarkers in hepatocellular carcinoma
  Muhammad-Redha Abdullah-Zawawi, Muhammad Irfan Abdul Jalal, Shing Cheng Tan, Loscheni Varma, Nur Alyaa Afifah Md Shahri, Mira Farzana Mohamad Mokhtar, Ryia Illani Mohd Yunos, Nurul Syakima Ab Mutalib, Rahman Jamal
  Egyptian Journal of Medical Human Genetics.2025;[Epub]     CrossRef
• Marine L-arginase encapsulated in poly (lactic-co-glycolic acid) nanoparticles: A novel anti-cancer strategy for effective hepatocellular carcinoma treatment in vitro and in vivo
  Amria M. Mousa, Mohamed Abdelraof, Amany A. Hassabo, Doaa A. Darwish, Mona M.A. Abdel-Mottaleb, Rasha M. Allam
  Journal of Drug Delivery Science and Technology.2025; 109: 106980.     CrossRef
• Redefining precision medicine in hepatocellular carcinoma through omics, translational, and AI-based innovations
  Rashi Jain, Sathish Kumar Mungamuri, Prabha Garg
  The Journal of Precision Medicine: Health and Disease.2025; 1: 100003.     CrossRef
• Myosteatosis and the survival of patients with hepatocellular carcinoma: a meta-analysis
  Yongjuan Wu, Guangyuan Cheng, Jun Han, Qingsong Yang
  Clinical and Experimental Medicine.2025;[Epub]     CrossRef
• Exploring the antitumor potential of cucurbitacin B in hepatocellular carcinoma through network pharmacology, molecular docking, and molecular dynamics simulations
  Hongyu Zhang, Baixiu Wu, Liuhua Ke, Xiaoyuan Fan, Liji Huang, Zheng Peng
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(11): 14751.     CrossRef
• Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways
  Hany M. Fayed, Gihan F. Asaad, Marawan A. Elbaset, Ola A. Sharaf, Sawsan S. Mahmoud, Mohamed M. Amin, Zeinab A. El-Gendy, Fatma A. Ibrahim, Sherein S. Abdelgayed, Rehab F. Abdel-Rahman
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(11): 16131.     CrossRef
• The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma
  Atsuto Katano
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Extracellular vesicles as a promising platform of precision medicine in liver cancer
  Keyang Xu, Qibiao Wu, Zhao Lingyun, Romario Nguyen, Fatema Safri, William Yang, Yikun Xu, Yun Ye, Hiu Yee Kwan, Qiang Wang, Xiuming Liang, Muhammad J.A. Shiddiky, Majid E. Warkiani, Jacob George, Liang Qiao, Jianfeng Bao
  Pharmacological Research.2025; 217: 107800.     CrossRef
• Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report
  Tho Tran Dinh, Sy Than Van, Vinh Chu Van, Phuc Chu Minh
  Cureus.2025;[Epub]     CrossRef
• Association between early job loss and prognosis among hepatocellular carcinoma survivors
  B Yun, J Oh, S H Ahn, B K Kim, J-H Yoon
  Occupational Medicine.2025; 75(2): 113.     CrossRef
• All-cause and disease-specific mortality in young adults with MASLD: A nationwide cohort study
  Jeayeon Park, Goh Eun Chung, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Eun Ju Cho
  JHEP Reports.2025; 7(9): 101477.     CrossRef
• Low-Abundance Serum Protein Biomarker Candidates for HCC in Patients with Liver Cirrhosis
  Muhammad Salman Sajid, Rency S. Varghese, Alexander Kroemer, Habtom W. Ressom
  Journal of Proteome Research.2025; 24(7): 3656.     CrossRef
• Roadmap for HCC Surveillance and Management in the Asia Pacific
  Masatoshi Kudo, Bui Thi Oanh, Chien-Jen Chen, Do Thi Ngat, Jacob George, Do Young Kim, Luckxawan Pimsawadi, Pisit Tangkijvanich, Raoh-Fang Pwu, Rosmawati Mohamed, Sakarn Bunnag, Sheng-Nan Lu, Sirintip Kudtiyakarn, Tatsuya Kanto, Teerha Piratvisuth, Chao-C
  Cancers.2025; 17(12): 1928.     CrossRef
• Computational Repurposing of Approved Drugs: Exploring New Therapeutic Avenues for Liver Disorders
  Pranali Jadhav, Asha Thomas, Somdatta Chaudhari, Sohan Chitlange
  Journal of Pharmaceutical Innovation.2025;[Epub]     CrossRef
• Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches
  Sherif A. El-Kafrawy, Mostafa S. Elkafrawy, Esam I. Azhar, Anwaar Saeed, Ashraf A. Tabll
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Pathogenic effects of telomerase reverse transcriptase (TERT) promoter mutations in nonalcoholic steatohepatitis (NASH) related hepatocellular carcinoma (HCC) and its potentials as a diagnostic biomarker
  Usman Umar Liman, Asanka Sudeshini Hawage, Sumadee De Silva, Saumya Madushani Samarasinghe, Kamani Hemamala Tennekoon, Rohan Chaminda Siriwardana, Madunil Anuk Niriella
  Egyptian Journal of Medical Human Genetics.2025;[Epub]     CrossRef
• Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression
  Yang-Hsiang Lin, Ming-Wei Lai, Chau-Ting Yeh, Wey-Ran Lin
  Cancer Cell International.2025;[Epub]     CrossRef
• Burden of liver cancer in the European region from 1990 to 2021: a sub-analysis of the global burden of disease study
  Onika Kazi, Shokoufeh Hamidzadeh, Babak Ehsani Zunuz, Abdolsabour Khordoo, Seyede Saba Mazloomi, Hossein Khademsedaghat, Mohammad Amin Khadembashiri
  Annals of Medicine & Surgery.2025; 87(7): 4053.     CrossRef
• Systemic treatment of liver cancer: Current status and future perspectives
  Chun-Bo Li, Yu-Ting Ning, Nai-Ying Shen, Ben Wang, Han Xiao, Gang Luo
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review
  Mario Romeo, Fiammetta Di Nardo, Carmine Napolitano, Claudio Basile, Carlo Palma, Paolo Vaia, Marcello Dallio, Alessandro Federico
  Diabetology.2025; 6(8): 79.     CrossRef
• Rapid Bone Metastasis in Hepatocellular Carcinoma: A Case Report
  Laraib ., Uzma Khalid, Ayesha Khalid
  Cureus.2025;[Epub]     CrossRef
• Multi-Omics Feature Selection to Identify Biomarkers for Hepatocellular Carcinoma
  Rency S. Varghese, Xinran Zhang, Sarada Giridharan, Muhammad Salman Sajid, Md Mamunur Rashid, Alexander Kroemer, Habtom W. Ressom
  Metabolites.2025; 15(9): 575.     CrossRef
• The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype–phenotype study
  Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Heechul Nam, Mi Young Byun, Seok Keun Cho, Jinsung Park, Hyuk Wan Ko, Seong Wook Yang, Pil Soo Sung, Si Hyun Bae
  Journal of Gastroenterology.2025; 60(10): 1284.     CrossRef
• Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma
  Xuemei Yang, Weiguang Chen, Haitao Sun, Weicong Chen, Wei Xu, Chunyu He, Yang Liu, Ying Kuang, Yanhao Ma, Binglian Zhong, Chaojie Li, Guohuan Li, Qingfeng Du, Songqi He
  Chinese Medicine.2025;[Epub]     CrossRef
• Direct-acting Antivirals Therapy for Hepatocellular Carcinoma in Hepatitis C Patients
  Seul Ki Han, Soon Koo Baik, Moon Young Kim
  Journal of Digestive Cancer Research.2025; 13(2): 150.     CrossRef
• Quantum chemical optimization and residue-specific stabilization of CDK20 inhibitors in hepatocellular carcinoma
  Ahmed I. Foudah, Mohammed H. Alqarni, Tariq M. Aljarba, Talha Jawaid, Osama A. Alkhamees, Saud M. Alsanad, Khalid I. AlHussaini, Aftab Alam
  Molecular Diversity.2025;[Epub]     CrossRef
• Association between metabolites and hepatocellular carcinoma: findings from a two-sample Mendelian randomization study
  Tung Hoang, Van Mai Truong, Tho Thi Anh Tran, Bao Le Thai Tran, Ngoc Hong Cao
  Journal of Liver Cancer.2025; 25(2): 251.     CrossRef
• Fig Seed Oil Induces Mitochondrial-Mediated Apoptosis in HepG2 Cells
  Adem Yavaş
  SDÜ Tıp Fakültesi Dergisi.2025; 32(3): 230.     CrossRef
• Heme Oxygenase-1 Expression as a Prognostic Marker in Early-Stage HCC Undergoing Resection or Liver Transplantation
  Ramona Cadar, Alin Mihai Vasilescu, Ana Maria Trofin, Alexandru Grigorie Nastase, Mihai Zabara, Cristina Muzica, Corina Lupascu Ursulescu, Mihai Danciu, Andrei Pascu, Iulian Buzincu, Delia Ciobanu, Ianole Victor, Cristian Dumitru Lupascu
  Life.2025; 15(10): 1589.     CrossRef
• Quantification, antioxidant, in-silico molecular docking and anti-hepatocellular carcinoma activity of Sepia ink polysaccharides prepared from Sepia pharaonis
  Sandhanam Kuppusamy, Bedanta Bhattacharjee, Abarnadevika Alagiri, Sumithra Mohan, Ram Kumar Sahu, Abhishek Bhattacharjee, Chitra Vellapandian
  Future Journal of Pharmaceutical Sciences.2025;[Epub]     CrossRef
• MicroRNA Landscape in Hepatocellular Carcinoma: Metabolic Re-Wiring, Predictive and Diagnostic Biomarkers, and Emerging Therapeutic Targets
  Dimitris Liapopoulos, Panagiotis Sarantis, Theodora Biniari, Thaleia-Eleftheria Bousou, Eleni-Myrto Trifylli, Ioanna A. Anastasiou, Stefania Kokkali, Dimitra Korakaki, Spyridon Pantzios, Evangelos Koustas, Ioannis Elefsiniotis, Michalis V. Karamouzis
  Biomedicines.2025; 13(9): 2243.     CrossRef
• Current status and future perspectives of minimally invasive liver surgery for hepatocellular carcinoma
  Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, Hyelim Joo, Seung Yeon Lim
  Journal of Liver Cancer.2025; 25(2): 233.     CrossRef
• Navigating liver cancer with mouse models: a comprehensive overview of HCC experimental systems
  Ga-Young Kim, Dokyung Kim, Jaehyun Jeon, Wonhyo Seo, Seol Hee Park
  Journal of Liver Cancer.2025; 25(2): 239.     CrossRef
• Effects of the Polar Fraction of Lophocereus schottii on Gene Expression and Hepatocyte Proliferation in a Wistar Rat Model of Hepatocellular Carcinoma
  Marina Campos-Valdez, Jaime Sánchez-Meza, Arturo Orozco-Barocio, José A. Domínguez-Rosales, Juliana Marisol Godínez-Rubí, Sarai C. Rodríguez-Reyes, Erika Martínez-López, Miriam R. Bueno-Topete, Manuel A. Castro-García, Guillermo M. Zúñiga-González, Daniel
  International Journal of Molecular Sciences.2025; 26(19): 9788.     CrossRef
• Radiomic Analysis in Hepatocellular Carcinoma: Prospects and Clinical Benefits (Review)
  E. B. Kodzoeva, K. A. Romanova, B. M. Medvedeva, N. Ts. Drobot
  Journal of oncology: diagnostic radiology and radiotherapy.2025; 8(3): 78.     CrossRef
• Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3–Targeting Compound for Imaging of Hepatocellular Carcinoma
  Oliver Viering, Julia Brosch-Lenz, Ralph A. Bundschuh, Helen Scholtissek, Johanna S. Enke, Adriana Amerein, Georgine Wienand, Alexander Dierks, Malte Kircher, Marianne Patt, Christian H. Pfob, Constantin Lapa
  Journal of Nuclear Medicine.2025; : jnumed.125.270267.     CrossRef
• Evaluating the Antitumor Effect of Root Extract of Salvadora persica in Hepatocarcinoma Through the Induction of Apoptosis via an Intrinsic Pathway: An In Vitro Study
  Fouzia Latif, Kong Qun, Mingjing Lu
  Cureus.2025;[Epub]     CrossRef
• Nationwide analysis of renal outcomes in chronic hepatitis B patients treated with Tenofovir Alafenamide vs. Entecavir
  Hyuk Kim, Jae Young Kim, Hye-Jin Yoo, Log Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Arachidonic Acid Induces Ferroptosis in Hepatocellular Carcinoma via the SIRT5-ACSL4/LPCAT3/ALOX15 Axis, Leading to Lipid Peroxidation and Mitochondrial Dysfunction
  Peisen Xue, Jingting Zhang, Zhibing Wang, Ling Wu, Jincheng Tang, Renyi Yang, Wenhui Gao, Puhua Zeng
  Phytomedicine.2025; : 157450.     CrossRef
• Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma
  Susan J. Kim, Kaelyn C. Cummins, Allan Tsung
  Cancers.2024; 16(10): 1852.     CrossRef
• Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
  Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
  International Journal of Molecular Sciences.2024; 25(13): 7191.     CrossRef
• Impacts of smoking on alcoholic liver disease: a nationwide cohort study
  Jeong-Ju Yoo, Dong Hyeon Lee, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Log Young Kim
  Frontiers in Public Health.2024;[Epub]     CrossRef
• Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies
  Fouad Jaber, George Cholankeril, Hashem B El-Serag
  Journal of the Canadian Association of Gastroenterology.2024; 7(5): 331.     CrossRef
• Development and validation of a prognostic nomogram to predict the recurrence of AFP-negative and DCP-positive hepatocellular carcinoma after curative resection
  Junnan Li, Qi Wang, Yadong Yan, Lina Sun, Gongming Zhang, Guangming Li, Ronghua Jin
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
  Baofa Yu, Wenxue Ma
  Cytokine & Growth Factor Reviews.2024; 79: 29.     CrossRef
• Mapping the Hidden Terrain of Hepatocellular Carcinoma: Exploring Regional Differences in Incidence and Mortality across Two Decades by Using the Largest US Datasets
  Yazan Abboud, Vraj P. Shah, Michael Bebawy, Ahmed Al-Khazraji, Kaveh Hajifathalian, Paul J. Gaglio
  Journal of Clinical Medicine.2024; 13(17): 5256.     CrossRef
• Bridging hope: Retrospective analysis of stereotactic radiotherapy in patients with hepatocellular carcinoma-A promising and cost-effective solution for low-and middle-income countries
  Rakesh Kapoor, Treshita Dey, Divya Khosla, Sunil Taneja, Naveen Kalra, Rajesh Gupta
  Cancer Research, Statistics, and Treatment.2024; 7(3): 326.     CrossRef
• Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma – An Observational Study from Taiwan
  Chi-Han Lin, Yung-Chia Kuo, Hsuan-Chih Kuo, Ching-Ting Wang, Shi-Ming Lin, Alan Chao-Wei Lee, Ming-Chin Yu, Wei-Chen Lee, Cherry Chiao-Erh Chen, Jason Chia-Hsun Hsieh
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1875.     CrossRef
• A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
  Yoon-E Shin, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(10): 1634.     CrossRef
• Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma
  Peijun Xu, Maoyun Liu, Miao Liu, Ai Shen
  BioScience Trends.2024; 18(5): 431.     CrossRef
• Gene targets with therapeutic potential in hepatocellular carcinoma
  Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi, Zulvikar Syambani Ulhaq
  World Journal of Gastrointestinal Oncology.2024; 16(12): 4543.     CrossRef
• Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
  Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  The Korean Journal of Internal Medicine.2024; 39(6): 931.     CrossRef
• Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
  Han Ah Lee
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Lower Incidence of Hepatocellular Carcinoma with Tenofovir Alafenamide in Chronic Hepatitis B: Evidence from a Large-Scale Cohort
  Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Hye Won Lee, Sang Gyune Kim, Young Seok Kim
  JHEP Reports.2024; : 101268.     CrossRef
• Microwave ablation versus single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized control trial
  Katsutoshi Sugimoto, Kento Imajo, Hidekatsu Kuroda, Go Murohisa, Kazue Shiozawa, Kentaro Sakamaki, Takuya Wada, Hirohito Takeuchi, Kei Endo, Tamami Abe, Takashi Matsui, Takahiro Murakami, Masato Yoneda, Atsushi Nakajima, Shigehiro Kokubu, Takao Itoi
  JHEP Reports.2024; : 101269.     CrossRef
• The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
  Wonju Chung, Haeryoung Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
  Thang Viet Luong, Nam Van Duc Nguyen, Linh Duy Le, Hieu Nguyen Hoang Minh, Hai Nguyen Ngoc Dang
  World Journal of Gastroenterology.2024; 30(47): 4983.     CrossRef
• Predicting Microvascular Invasion in Liver Transplant Recipients for Hepatocellular Carcinoma
  Usman I Aujla, Imran Ali Syed, Kashif Rafi, Ammara Naveed, Ahmad K Malik, Muhammad Yasir Khan, Ihsan Ul Haq, Sohail Rashid, Osama T Butt, Faisal Dar
  Cureus.2024;[Epub]     CrossRef
• The Influence of Sex and Age on Survival in Patients with Hepatocellular Carcinoma
  Iuliana Pompilia Radu, Bernhard Scheiner, Jonas Schropp, Maria Gabriela Delgado, Birgit Schwacha-Eipper, Chaonan Jin, Jean-Francois Dufour, Matthias Pinter
  Cancers.2024; 16(23): 4023.     CrossRef
• Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
  Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro
  Viruses.2024; 16(12): 1899.     CrossRef
• Statin use and liver-related prognosis among patients with MASLD
  Byungyoon Yun, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon
  JHEP Reports.2024; : 101313.     CrossRef
• Long-term results of surgical treatment of hepatocellular cancer in Russian real practice
  V. V. Petkau, R. I. Rasulov, A. A. Muratov, G. V. Nurbekyan, I. B. Uvarov, A. A. Kirshin, R. V. Orlova, N. V. Popova, M. S. Dinikin, R. Yu. Khlobystin, A. V. Sultanbaev, K. V. Menshikov, O. G. Orlov
  Meditsinskiy sovet = Medical Council.2024; (21): 114.     CrossRef
• Overall Survival and the Impact of Albumin-bilirubin Grade in Patients with Advanced Hepatocellular Carcinoma: Data from a Tertiary Care Hospital in a Lower-middle-income Country
  Mohammad SS Naviwala, Waqas A Khan, Adeeba Zaki, Mahnoor Tariq, Faiza Ahmed, Warda Saleem, Munira Moosajee, Yasmin A Rashid
  Euroasian journal of hepato-gastroenterology.2024; 14(2): 251.     CrossRef
• The roles and mechanisms of miRNA in HBV-HCC carcinogenesis: Why no therapeutic agents after 30 years?
  KURT SARTORIUS, BENN SARTORIUS, CHERIE WINKLER, ANIL CHUTURGOON, ANNA KRAMVIS, PING AN, WEIGANG ZHANG, YUNJIE LU
  BIOCELL.2024; 48(11): 1543.     CrossRef

Citations

Citations to this article as recorded by  

• The multifaceted anticancer potential of luteolin: involvement of NF-κB, AMPK/mTOR, PI3K/Akt, MAPK, and Wnt/β-catenin pathways
  Deepika Singh, Gaurav Shukla
  Inflammopharmacology.2025; 33(2): 505.     CrossRef
• Coenzyme Q and Selenium Co-Supplementation Alleviate Methionine Choline-Deficient Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Mice
  Hyewon Choi, Jiwon Choi, Yula Go, Jayong Chung
  Nutrients.2025; 17(2): 229.     CrossRef
• Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
  Jae-Young Kim, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Hepatology International.2025; 19(4): 959.     CrossRef
• MASLD or MAFLD: fatty liver by any name will pose the same challenge
  Anil Chandra Anand, Dibyalochan Praharaj
  Metabolism and Target Organ Damage.2025;[Epub]     CrossRef
• Glycoproteomics of Gastrointestinal Cancers and Its Use in Clinical Diagnostics
  Tomas Bertok, Andrea Pinkeova, Lenka Lorencova, Anna Datkova, Michal Hires, Eduard Jane, Jan Tkac
  Journal of Proteome Research.2025; 24(6): 2584.     CrossRef
• Protective effects of Ginkgo biloba supplementation on clinical outcomes in metabolic dysfunction-associated steatotic liver disease
  Tom Ryu, Beom Sun Chung, Jaejun Lee, Ji Won Han, Hyun Yang, Keungmo Yang
  Phytomedicine.2025; 143: 156889.     CrossRef
• Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea
  Dong Wook Kim, Minkook Son, Hye Jung Lee, Chi Hyeon Choi, Yeo Wool Kang, Sang Yi Moon, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek, Won Suk An
  Hepatology Research.2025; 55(9): 1239.     CrossRef
• Navigating the weight: The impact of obesity on gastrointestinal cancer surgery and strategies for improved outcomes
  Gerardo Sarno, Claudia Reytor-González, Evelyn Frias-Toral, Martín Campuzano-Donoso, Christos S. Katsanos, Daniel Simancas-Racines
  Seminars in Cancer Biology.2025; 114: 138.     CrossRef
• Clinical risk factors for hepatocellular carcinoma in Southeast Louisiana: a matched case–control study
  Gabrielle V. Gonzalez, Denise M. Danos, Tekeda F. Ferguson, George Therapondos, Mei-Chin Hsieh, Claudia Leonardi
  Cancer Causes & Control.2025;[Epub]     CrossRef
• Proteoform Patterns in Hepatocellular Carcinoma Tissues: Aspects of Oncomarkers
  Elena Zorina, Natalia Ronzhina, Olga Legina, Nikolai Klopov, Victor Zgoda, Stanislav Naryzhny
  Proteomes.2025; 13(3): 27.     CrossRef
• Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050
  Jianing Shi, Xuan Wu, Jiali Yu, Qingli Zhou
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• The Impact of Menopausal Hormone Therapy on Liver and Biliary Tract Health
  A. O. Bueverov, N. I. Tapilskaya
  Russian Journal of Gastroenterology, Hepatology, Coloproctology.2025; 35(3): 104.     CrossRef
• 15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry
  Songgyung Kim, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Ki-Hun Kim, Jonggi Choi
  Gut and Liver.2025; 19(5): 746.     CrossRef
• Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation
  Bootsakorn Boonkaew, Denita Charoenthanakitkul, Nuchanart Suntornnont, Chaiyaboot Ariyachet, Pisit Tangkijvanich
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Overnutrition and Lipotoxicity: Impaired Efferocytosis and Chronic Inflammation as Precursors to Multifaceted Disease Pathogenesis
  Vivek Mann, Alamelu Sundaresan, Shishir Shishodia
  Biology.2024; 13(4): 241.     CrossRef
• Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
  Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Liver Cancer.2024; 13(5): 561.     CrossRef
• Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
  Young-Gi Song, Kyeong-Min Yeom, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
  Liver Cancer.2024; : 1.     CrossRef
• Emerging role of exosomal microRNA in liver cancer in the era of precision medicine; potential and challenges
  Tarek El Hayek, Osama Abdulwahab Alnaser-Almusa, Sulaiman Mamoun Alsalameh, Maya Taofik Alhalabi, Ahmad Nedal Sabbah, Eman Abdullah Alshehri, Tanveer Ahmad Mir, Naresh Kumar Mani, Khaled Al-Kattan, Raja Chinnappan, Ahmed Yaqinuddin
  Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
• Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study
  Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  BMC Public Health.2024;[Epub]     CrossRef
• Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
  Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp, Derek J. Erstad
  Cancers.2024; 16(16): 2773.     CrossRef
• NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors
  Nutan Sharma, Lakhwinder Singh, Aditya Sharma, Ajay Kumar, Dinesh Mahajan
  Pharmacological Research.2024; 208: 107375.     CrossRef
• Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva
  Noah J. Daniels, Courtney E. Hershberger, Matthew Kerosky, Chase J. Wehrle, Roma Raj, Nihal Aykun, Daniela S. Allende, Federico N. Aucejo, Daniel M. Rotroff
  International Journal of Molecular Sciences.2024; 25(18): 10144.     CrossRef
• The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
  Wonju Chung, Haeryoung Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
  Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  The Korean Journal of Internal Medicine.2024; 39(6): 931.     CrossRef
• Ruptured hepatocellular carcinoma developed in a normal liver in a young patient with a body mass index of 33 kg/m2
  Naoki Kirihata, Yoshiko Nakano, Koki Moriyoshi, Shin'ichi Miyamoto
  BMJ Case Reports.2024; 17(12): e262841.     CrossRef
• Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
  Jeong-Ju Yoo, Man Young Park, Eun Ju Cho, Su Jong Yu, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon
  Journal of Clinical Medicine.2023; 12(9): 3336.     CrossRef
• Reply: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation
  Jeong-Ju Yoo, Sang Gyune Kim
  Liver Transplantation.2023; 29(11): E38.     CrossRef
• Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions
  Thi Ha Nguyen, Tuan Minh Nguyen, Dinh Thi Minh Ngoc, Taesik You, Mi Kyung Park, Chang Hoon Lee
  International Journal of Molecular Sciences.2023; 24(22): 16255.     CrossRef
• Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
  Ji Kim, Hee-Chul Nam, Chang-Wook Kim, Hee Cho, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Hyun Yang, Si Bae, Suho Kim, Jung Oh, Ho Chun, Chang Jeon, Jaegyoon Ahn, Pil Sung
  Cancers.2023; 15(17): 4233.     CrossRef
• A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly
  Jeong-Ju Yoo, Jayoun Lee, Gi Hong Choi, Min Woo Lee, Dong Ah Park
  Scientific Reports.2023;[Epub]     CrossRef